News
How a New Weight-Loss Pill Could Transform Health
Story In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top executives met, like they had dozens of times before, to hear the long-awaited results of a study involving a new drug.
You can use Wegovy (semaglutide) as long as you need for weight loss and weight management. You can continue taking Wegovy if you and your doctor determine that Wegovy is safe for you and ...
For these reasons, people are taking to “microdosing” weight-loss drugs, or using less than the dose recommended by the ...
The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.
Injectable medications originally developed for the treatment of diabetes are also effective for weight loss , and have ...
Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...
Currently, only liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound) are approved for weight loss, though some other GLP-1 drugs may be prescribed off-label. Keep in mind that ...
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...
In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...
The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...
Some of the more than a dozen states that cover GLP-1 drugs like Wegovy, Ozempic and Zepbound through Medicaid are scrambling ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback